Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-01

Clinical Trial Update: Adjunctive Linezolid for the Treatment of Tuberculous Meningitis [Phase 2]

View source ↗

Summary

Phase 2 trial of adjunctive linezolid for tuberculous meningitis has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Tuberculosis, Meningeal | Phase 2 | Status: COMPLETED | Results posted: 2024-10-01